year 11, Issue 1 (March - April 2017)
Iran J Med Microbiol 2017, 11(1): 1-8 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Tavakoli A, Karbalaie Niya M H, Keshavarz M, Safarnezhad Tameshke F, Monavari S H. Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Iran J Med Microbiol 2017; 11 (1) :1-8
URL: http://ijmm.ir/article-1-582-en.html
URL: http://ijmm.ir/article-1-582-en.html
Ahmad Tavakoli1 
, Mohammad Hadi Karbalaie Niya1 , Mohsen Keshavarz1 , Fahimeh Safarnezhad Tameshke2 , Seyed Hamidreza Monavari 3
, Mohammad Hadi Karbalaie Niya1 , Mohsen Keshavarz1 , Fahimeh Safarnezhad Tameshke2 , Seyed Hamidreza Monavari 3
1- Department of Virology, Faculty of medicine, Iran University of Medical Sciences, Tehran, Iran
2- Gastrointestinal & Liver Disease Research Center (GILDRC), Iran University of Medical Sciences, Tehran, Iran
3- Department of Virology, Faculty of medicine, Iran University of Medical Sciences, Tehran, Iran ,hrmonavari@yahoo.com
2- Gastrointestinal & Liver Disease Research Center (GILDRC), Iran University of Medical Sciences, Tehran, Iran
3- Department of Virology, Faculty of medicine, Iran University of Medical Sciences, Tehran, Iran ,
Abstract: (29968 Views)
The Middle East respiratory syndrome coronavirus (MERS-CoV) as a causative agent of severe lower respiratory tract infection in humans, considered as a global threat, especially against to Persian Gulf countries. Since its discovery in 2012, MERS-CoV has spread 27 countries affecting about 1800 people and caused more than 600 deaths in worldwide. In comparison to SARS (severe acute respiratory syndrome), MERS-CoV appears to have a higher mortality rate (40% versus 10%) and is particularly more severe in patients with underlying medical conditions. Until now, the most MERS-CoV cases (more than 85 percent) have had a history of travel or residence in the Middle East countries. A possible intermediate host for MERS-CoV is camel. Clinical manifestations of MERS range from mild or asymptomatic disease to acute respiratory syndrome and multi-organ failure resulting in death, mostly in individuals with preexisting medical co-morbidities. There is no specific antiviral treatment for MERS and infection prevention and control practices are necessary to prevent spread of MERS-CoV in health care facilities. In present study, we have briefly outlined the recent information about the epidemiology, clinical features, diagnosis, treatment and prevention of MERS-CoV.
Type of Study: Review Article |
Subject:
Medical Virology
Received: 2016/06/24 | Accepted: 2017/01/24 | ePublished: 2017/03/16
Received: 2016/06/24 | Accepted: 2017/01/24 | ePublished: 2017/03/16
References
1. Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367(19):1814-20. [Article]
2. Al-Tawfiq JA, Perl TM. Middle East respiratory syndrome coronavirus in healthcare settings. Curr Opin Infect Dis 2015; 28(4):392-6. [PubMed]
3. Cowling BJ, Park M, Fang VJ, Wu P, Leung GM, Wu JT. Preliminary epidemiologic assessment of MERS-CoV outbreak in South Korea, May–June 2015. Euro Surveill 2015; 20(25):18-22. [PubMed]
4. Kim JY, Song JY, Yoon YK, Choi S-H, Song YG, Kim S-R, et al. Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities. Infect Chemother 2015; 47(4):278-302. [PubMed]
5. Mohd HA, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir. Virol J 2016; 13(1):1. [Article]
6. Scobey T, Yount BL, Sims AC, Donaldson EF, Agnihothram SS, Menachery VD, et al. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc Natl Acad Sci 2013; 110(40):16157-62. [Article]
7. Zhang Z, Shen L, Gu X. Evolutionary Dynamics of MERS-CoV: Potential Recombination, Positive Selection and Transmission. Sci Rep 2016; 6:111-15. [PubMed]
8. Mou H, Raj VS, Van Kuppeveld FJ, Rottier PJ, Haagmans BL, Bosch BJ. The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J Virol 2013; 87(16):9379-83. [PubMed]
9. Matthews KL, Coleman CM, van der Meer Y, Snijder EJ, Frieman MB. The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling. J Gen Virol 2014; 95(4):874-82. [PubMed]
10. Oboho IK, Tomczyk SM, Al-Asmari AM, Banjar AA, Al-Mugti H, Aloraini MS, et al. 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. N Engl J Med 2015; 372(9):846-54. [Article]
11. Petersen E, Pollack MM, Madoff LC. Health-care associate transmission of Middle East respiratory syndrome corona virus, MERS-CoV, in the Kingdom of Saudi Arabia. Int J Infect Dis 2014; 29:299-300. [Article]
12. Mortazavi HS, Monavari SH, Ataei Pirkooh A, Tavakoli A. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): A Review Article. Iran J Virol 2014; 8(2):59-68. [Article]
13. Chowell G, Blumberg S, Simonsen L, Miller MA, Viboud C. Synthesizing data and models for the spread of MERS-CoV, 2013: key role of index cases and hospital transmission. Epidemics 2014; 9:40-51. [PubMed]
14. Balkhair A, Alawi FB, Al Maamari K, Al Muharrmi Z, Ahmed O. MERS-CoV: Bridging the knowledge gaps. Oman Med J 2014; 29(3):169-71. [PubMed]
15. de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol 2013; 87(14):7790-2. [PubMed]
16. Woo PC, Lau SK, Li KS, Poon RW, Wong BH, Tsoi H-w, et al. Molecular diversity of coronaviruses in bats. Virology 2006; 351(1):180-7. [PubMed]
17. Watson JT, Hall AJ, Erdman DD, Swerdlow DL, Gerber SI. Unraveling the mysteries of Middle East respiratory syndrome coronavirus. Emerg Infect Dis 2014; 20(6):1054-9. [Article]
18. Haagmans BL, Al Dhahiry SH, Reusken CB, Raj VS, Galiano M, Myers R, et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis 2014; 14(2):140-5. [Article]
19. Al-Tawfiq JA, Hinedi K, Ghandour J, Khairalla H, Musleh S, Ujayli A, et al. Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clin Infect Dis 2014:ciu226. [PubMed]
20. Moniri A, Marjani M, Tabarsi P, Yadegarynia D, Nadji SA. Health Care Associated Middle East Respiratory Syndrome (MERS): A Case from Iran. Tanaffos 2015; 14(4):262-9. [PubMed]
21. Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen KY. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 2015; 28(2):465-522. [Article]
22. Bermingham A, Chand M, Brown C, Aarons E, Tong C, Langrish C, et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill 2012; 17(40):224-9. [PubMed]
23. Drosten C, Seilmaier M, Corman VM, Hartmann W, Scheible G, Sack S, et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 2013; 13(9):745-51.
24. Das KM, Lee EY, Enani MA, AlJawder SE, Singh R, Bashir S, et al. CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus. Am J Roentgenol 2015; 204(4):736-42. [PubMed]
25. Omrani AS, Saad MM, Baig K, Bahloul A, Abdul-Matin M, Alaidaroos AY, et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis 2014; 14(11):1090-5. [Article]
26. Graham RL, Donaldson EF, Baric RS. A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol 2013; 11(12):836-48. [PubMed]
27. Memish ZA, Al-Tawfiq JA, Assiri A, AlRabiah FA, Al Hajjar S, Albarrak A, et al. Middle East respiratory syndrome coronavirus disease in children. Pediatr Infect Dis J 2014; 33(9):904-6. [PubMed]
28. MDas K, YLee E. Middle East Respiratory Syndrome Coronavirus in Children. Indian Pediatr 2016; 53(8):752-6.
29. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet 2015; 386(9997):995-1007. [PubMed]
30. Yousefi M, Dehesh MM, Farokhnia M. Epidemiological and clinical characteristics of patients with Middle East Respiratory syndrome Coronavirus in Iran in 2014. Jpn J Infect Dis 2016(0):145-8. [PubMed]
31. Gautret P, Benkouiten S, Salaheddine I, Parola P, Brouqui P. Preventive measures against MERS-CoV for Hajj pilgrims. Lancet Infect Dis 2013; 13(10):829-31. [PubMed]
32. Yavarian J, Rezaei F, Shadab A, Soroush M, Gooya MM, Azad TM. Cluster of Middle East respiratory syndrome coronavirus infections in Iran, 2014. Emerg Infect Dis 2015; 21(2):362-4. [Article]
33. Shapiro M, London B, Nigri D, Shoss A, Zilber E, Fogel I. Middle East respiratory syndrome coronavirus: review of the current situation in the world. Disaster Mil Med 2016; 2(1):9. [Article]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright Policy
Iranian Journal of Medical Microbiology by Farname is licensed under CC BY-NC 4.0
